Parkinson’s UK and the University of Sheffield have launched a groundbreaking ‘virtual biotech’ company to develop new treatments for Parkinson’s disease.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.